Software Stumble Overshadows a Clean Beat; Initiating IBM at Hold as the Re-Rating Outruns the Growth

Results vs. Consensus

Year-over-Year Comparison

Assessment

Revenue. The 5% constant-currency print is the fastest IBM has grown in this reporting structure and, importantly, it was broad enough that a soft Consulting line did not derail it. But the composition matters for how the market pays for this business: Infrastructure, the lowest-multiple, most cyclical segment, was the swing factor, up 11% cc on the z17 launch, while Software, the segment that justifies the re-rating, grew 8% cc with organic growth we estimate in the mid-single digits once HashiCorp and DataStax are stripped out. Fast revenue of the wrong composition is why a 2.3% top-line beat produced a 7.6% sell-off.

Margins. Margin is the cleanest part of the quarter and the least appreciated. Operating gross margin of 60.1% (up 230 bps) and adjusted EBITDA up 16% on 8% revenue growth show real operating leverage, and it is being manufactured internally: the productivity program that exited 2024 at $3.5B of run-rate savings is now targeted at roughly $4.5B by year-end, funded by IBM embedding its own AI across 70-plus internal workflows. That is a self-help lever that does not depend on the macro, and it is the most durable reason to own the stock.

EPS and cash. Operating EPS of $2.80 (up 15%) against a 5% cc revenue line is a 3x profit-to-revenue growth ratio, the signature of a mix-and-productivity story rather than a volume story. First-half free cash flow of $4.8B is a record first-half margin and puts the raised >$13.5B full-year target comfortably in reach; at the post-print price that is a free-cash-flow yield near 5.6%, which is the floor under the stock and the reason a full valuation is a Hold rather than a sell.

Segment Performance

Key portfolio KPIs

Software (+8% cc): the number that moved the stock

Software grew 8% at constant currency to $7.39B, with Red Hat accelerating a point sequentially to roughly 14.5% (OpenShift revenue up more than 20%, ARR $1.7B) and Automation up 14% as HashiCorp posted a strong first full quarter under IBM. The drag was Transaction Processing, down 2%, a deliberate consequence of the z17 launch: clients front-load hardware spend at the start of a mainframe cycle, and the higher-margin software that runs on that installed capacity lags by a few quarters. Management was explicit that this is the same pattern seen at the z16 launch a year earlier, and that Transaction Processing should return to growth in the second half.

"Software is now about 45% of our business with ARR growing 10%. ... We continue to expect Software revenue growth approaching double digits for the full year." — James Kavanaugh, CFO

Assessment: The reported 8% cc masks organic growth of roughly 3-4% once HashiCorp and DataStax are removed, and that is the crux of the bear case: the acceleration IBM is guiding to leans on M&A synergies and a Transaction Processing rebound that has not yet arrived. The pieces are credible, but "approaching double digits" is now a from-here claim rather than a demonstrated trend, and the market repriced accordingly.

Infrastructure (+11% cc): z17 carries the quarter

Infrastructure jumped 14% (11% cc) as IBM Z rose 67% cc on the strongest-ever launch-quarter start for a new mainframe, with management noting it shipped more than 100% of a normal launch quarter's MIPS capacity. The z17's Telum II processor and the forthcoming Spyre accelerator position the mainframe as an AI-inference platform for transactional workloads, which is the strategic bridge between IBM's oldest franchise and its newest one. Distributed Infrastructure fell 17% on a Power product transition ahead of the July Power11 launch.

"We run that mainframe platform as a stack economic play, $3 to $4, a platform multiplier over the cycle. ... We shipped over 100% MIPS capacity into the marketplace on z17." — James Kavanaugh, CFO

Assessment: Infrastructure is doing exactly what it should at the front of a mainframe cycle, and the $3-4 platform multiplier is the mechanism that should convert this hardware surge into Transaction Processing software revenue in 2026-2027. The catch for the equity is that a mainframe-led beat is the lowest-quality kind of upside in a market paying for software; it flatters the current quarter but does not re-rate the multiple.

Consulting (flat cc): stabilizing, not recovering

Consulting revenue was flat at constant currency, an improvement from the fourth quarter's decline but still a business fighting a weak discretionary-spending backdrop. Signings fell 18% in the quarter, which management attributed entirely to lapping a year-ago wave of large early renewals, low-to-no-margin contracts whose absence flatters realized economics. The offsets are a $32B backlog up 8% at spot rates, a book-to-bill of 1.14, net-new client penetration up 13%, and a GenAI consulting book that crossed $1B in the quarter and now exceeds $6B inception-to-date.

"Delayed decision-making, especially in discretionary projects, as well as prior year renewals impacted our in-period signings. However, we're seeing an improvement in strategic wins with new clients and expanding engagements with existing clients." — James Kavanaugh, CFO

Assessment: The "green shoots" framing (backlog, GenAI mix, net-new penetration) is genuine, but flat is flat, and Consulting remains the segment most exposed to a macro that management itself calls dynamic. We treat Consulting as a call option on a discretionary-spend recovery rather than a growth engine, and we would not underwrite the thesis on it.

Key Topics & Management Commentary

Overall Management Tone: Management was confident and notably more upbeat on the macro than a quarter ago, with the CEO explicitly upgrading his framing from "cautious optimism" to "optimism." The posture on the quarter's one weak spot, organic Software, was to explain the mix mechanics rather than concede a demand problem, and on Consulting the CFO volunteered the soft signings number before it was asked, which read as prepared rather than defensive. Where the call was least convincing was in bridging the demonstrated mid-single-digit organic Software growth to the "approaching double digits" full-year claim.

The Software growth bridge

The dominant analytical question of the call was how IBM gets from a Software line that grew 8% cc, with organic growth softer still, to the "approaching double digits" full-year guide. Management's bridge has four planks: Red Hat holding mid-teens (contributing ~3.5 points of Software growth, all organic), Automation running above model at mid-to-high teens on HashiCorp synergies (~3.5 points), Data delivering its model on GenAI momentum, and Transaction Processing swinging from a two-point first-half drag to low-single-digit full-year growth as the z17 MIPS base converts.

"Halfway through the year right now, we actually feel even more confident about the year of approaching double digits." — James Kavanaugh, CFO

Assessment: The bridge is arithmetically coherent but leans on two from-here inflections (an Automation acceleration and a Transaction Processing rebound) landing in the same second half. It is achievable; it is also exactly the kind of back-half-loaded guide that leaves no room for error, which is why the stock is not giving IBM the benefit of the doubt at this multiple.

The z17 mainframe cycle and the platform multiplier

The z17 launch is the quarter's clearest positive and the strongest start to a mainframe program in IBM's history. Beyond the immediate hardware revenue, the strategic point is the $3-4 of stack revenue (storage, software, services) that historically follows each dollar of mainframe capacity over the cycle, plus the z17's new role as an on-box AI inference engine via Telum II and the Q4 Spyre accelerator.

"More than 70% of IBM Z clients continue to expand or maintain capacity ... AI models can run directly on transactional workloads with no external servers needed." — Arvind Krishna, CEO

Assessment: The mainframe's durability keeps surprising skeptics, and embedding AI inference on-box is a genuinely differentiated answer for regulated, latency-sensitive transactional workloads. The multiplier is real but slow; it is a 2026-2027 tailwind to Transaction Processing, not a 2025 growth driver, and it argues for patience rather than for paying up today.

GenAI book of business crosses $7.5B

The generative-AI book of business reached more than $7.5B inception-to-date in roughly six quarters, split about $1.5B software and more than $6B consulting, and management said it is accelerating quarter over quarter. The mix skews to consulting because enterprises are paying IBM to architect and deploy AI, which management positions as the on-ramp to higher-margin software attach over time.

"Our GenAI book of business now stands at over $7.5 billion inception-to-date with momentum accelerating quarter-over-quarter." — Arvind Krishna, CEO

Assessment: The number is impressive and growing, but "book of business" is a cumulative signings metric, not recurring revenue, and its heavy consulting weighting means much of it is lower-margin and lumpier than a pure-software AI number would be. It is a real demand signal; it is not yet the software annuity the multiple is pricing.

Productivity and the internal AI flywheel

IBM raised its productivity-savings target to roughly $4.5B of annual run-rate by year-end, up from $3.5B at the end of 2024, achieved by embedding its own AI across more than 70 internal workflows. This is the "client zero" strategy, using IBM as the reference deployment for the software it sells, and it is directly funding the margin expansion.

"We are early in this client zero journey on scaling AI internally to reinvent the way we work." — James Kavanaugh, CFO

Assessment: This is the most underrated part of the story. A self-funded, macro-independent margin lever that also serves as a live proof point for the product is a rare combination, and it underwrites the raised operating-margin and free-cash-flow guides. It is the single most durable pillar of the bull case.

Capital allocation and the M&A environment

IBM spent $7.8B on acquisitions in the first half, driven largely by HashiCorp, pushing debt to $64.2B and goodwill to $67.5B, while still returning $3.1B in first-half dividends and declaring the 109th consecutive year of payouts. Management signaled appetite for more deals, calling the current regulatory backdrop a "rational regulation environment" where sensible M&A gets approved in reasonable timeframes.

"What we've seen over the last 4 months has made us optimistic that we are now in a rational regulation environment where M&A that makes sense will get approved in reasonable time frames." — Arvind Krishna, CEO

Assessment: The dividend is sacrosanct and well-covered by >$13.5B of free cash flow, but the acquisition pace is worth watching: leaning on M&A to hit a double-digit Software guide raises the organic-growth question rather than answering it, and the rising debt and goodwill balances are the price of that strategy. Disciplined so far, but a lever we will scrutinize.

AI: incremental demand versus cannibalization

Asked directly whether AI spend is incremental or cannibalizing other IT budgets, the CEO gave a layered answer: at the hardware and enabling-software layers AI is purely incremental, while the cannibalization is concentrated in labor, both clients' internal labor and third-party services, which is precisely where IBM's own Consulting business is exposed.

"The cannibalization is going to come from the fourth part. People are looking at their own internal labor expenses ... and they're looking to decrease those to make room for what they're doing around software." — Arvind Krishna, CEO

Assessment: This is an unusually candid admission that the AI wave is a structural headwind to labor-based consulting, IBM's own second-largest segment. Management's answer is to pivot Consulting toward transformative, partner-anchored projects that are harder to cannibalize, but it confirms why we treat Consulting as a melting-ice-cube-plus-option rather than a growth asset.

Federal and public-sector exposure

Management addressed the constrained first-half U.S. federal spending environment, framing the administration's early cost-cutting focus as now shifting toward modernization and AI adoption, which IBM is positioned to serve given its long federal track record.

"Their focus is now shifting to ... modernize the agencies in how they leverage technology ... I'm actually quite enthused by their ability to begin to make progress in the next few months." — Arvind Krishna, CEO

Assessment: Federal is a modest swing factor for IBM, and the "constrained but recovering" framing is reasonable but unproven. We would not underwrite a federal reacceleration into the model until signings confirm it; it is upside, not a base-case driver.

Guidance & Outlook

The shape of the guide is "hold the top line, raise everything below it." Revenue growth of at least 5% cc was reaffirmed rather than lifted despite a first-half beat, which management framed as prudence with two-thirds of free cash flow and roughly $40B of revenue still to come. Below the top line, the story is uniformly better: operating pre-tax margin expansion doubled to about a point, adjusted EBITDA growth was lifted to low teens (over $2B of year-on-year dollar growth), and the productivity target rose to $4.5B.

Implied second-half ramp: To reach "approaching double digits" Software growth for the year off a first-half that was softer, IBM needs Automation to hold mid-to-high teens, Red Hat to stay mid-teens, and Transaction Processing to swing from a two-point drag to low-single-digit growth. That is a back-half-weighted set of inflections.

Street at: Management explicitly said it is "comfortable with consensus estimates for revenue and profitability" for Q3, and that Q3 already embeds accelerating organic growth. Consensus for the year had already moved IBM revenue up more than $1B since January.

Guidance style: Characteristically conservative on revenue, more forthcoming on margin and cash. IBM has a multi-quarter pattern of guiding revenue modestly and beating, so the reaffirmed 5% top line likely embeds cushion; the risk is not the number but the composition needed to hit it.

Analyst Q&A Highlights

Software organic deceleration and the path back to double digits

The opening question went straight to the sore point: whether organic Software growth had decelerated for a third consecutive quarter to the low single digits, and how that squares with a near-double-digit full-year guide. Management did not dispute the trajectory; it reframed the second half around specific segment inflections, closing by noting that its Q3 guide already embeds accelerating organic growth.

Q: "It looks like organic growth decelerated in the quarter to maybe between 3% to 4%. ... that would imply it would be the third quarter of software organic growth deceleration. But you just expressed confidence in your approaching 10% guide. ... how much should we expect organic software growth to be for the remainder of the year?"
— Wamsi Mohan, Bank of America

A: "Halfway through the year right now, we actually feel even more confident about the year of approaching double digits. ... between accelerating growth continued on Red Hat, the Automation synergistic value on Hashi, Transaction Processing capitalizing on that multiplier effect ... And oh, by the way, we're comfortable with third quarter guidance, and third quarter guidance already accelerates organic growth."
— James Kavanaugh, CFO

Assessment: Management engaged the number honestly and gave a segment-by-segment bridge, which is the right answer, but it is a promise of reacceleration rather than evidence of it. The stock's reaction says the market wants proof, not a bridge.

Why not raise the revenue guide given the momentum?

A pointed challenge on conservatism: with free cash flow ahead of pace, the constant-currency growth rate already above 5%, and several segments set to accelerate, why only reaffirm the top line rather than raise it? Management leaned into the diversified, repositioned business model and pointed to how much it had already raised the year on margin, EBITDA, and cash, while noting how much of the year remains.

Q: "What is causing you not to raise guidance if you feel better about the economy? ... you're already at your 5%-plus and already ahead of pace on free cash flow?"
— Ben Reitzes, Melius Research

A: "We got a half a year to go. Free cash flow, we got 2/3 of our free cash flow to go. Revenue, we still got $40 billion worth of revenue to go. ... yes, we have upside and conservatism? Absolutely, but that's what you would expect of us." — James Kavanaugh, CFO

Assessment: The refusal to raise the revenue line while raising everything below it is the tell of the quarter. It is either genuine conservatism (IBM's habit) or quiet acknowledgment that the Software composition is not yet where it needs to be. We lean toward the former but respect that the tape read it as the latter.

Software durability into 2026

Looking past the current year, the question was whether Software growth can improve from the ~10% 2025 level into 2026 given the tailwinds described. The CEO expressed high confidence, arguing that Red Hat, Automation, and Data all carry equal-or-higher growth rates into next year, with Transaction Processing returning to its long-term low-to-mid-single-digit model as z17 capacity converts.

Q: "Heading into 2026 ... do you think there is potential for improving both organic and overall software growth heading into 2026 from the current 10% levels this year?"
— Jim Schneider, Goldman Sachs Asset Management

A: "All those 3 parts of the portfolio, I would give you equal or higher growth rates going into 2026. ... TP tends to be slightly lagging with the capacity that is being deployed on mainframes. ... I would fully expect TP to return to its long-term model." — Arvind Krishna, CEO

Assessment: A confident 2026 setup, but it is a year away and rests on the same TP-conversion and M&A-synergy planks as the 2025 bridge. Useful as thesis framing, not as a near-term catalyst.

AI incrementality versus cannibalization

One of the more revealing exchanges pressed on whether the AI book is incremental to client spend or cannibalizing IBM's other lines. The CEO drew a sharp distinction: incremental at the hardware and software layers, cannibalizing at the labor layer, which is where Consulting lives.

Q: "How are customers prioritizing AI over non-AI? Is there cannibalization in other areas of client spend or is it incremental to client spend?"
— Erik Woodring, Morgan Stanley

A: "From the semiconductors and the infrastructure level ... this is completely incremental. ... the enabling software layers, that is purely incremental. ... The cannibalization is going to come from the fourth part. People are looking at their own internal labor expenses, and ... third-party labor expenses, and they're looking to decrease those." — Arvind Krishna, CEO

Assessment: A candid, structurally important answer. Management is telling you that the AI wave lifts Software and Infrastructure while pressuring labor-based Consulting, which reframes IBM's own segment mix as a net beneficiary of the shift, provided Consulting keeps pivoting toward transformative work.

Macro read across geographies

Asked for a client-level read on a volatile macro, the CEO turned decisively optimistic, walking through Japan's reindustrialization, double-digit real growth in South Asia, a booming Gulf, resilient European tech demand, and North American enterprises using technology to scale revenue without proportionate capex or labor.

Q: "What are you hearing from your customers at this point given what seems to be a very volatile macro tape? ... categories where customers want to spend more money ... versus things they might be deemphasizing."
— Amit Daryanani, Evercore ISI

A: "I used the word cautious optimism at the end of the first quarter. I would now turn my way all the way to optimism around the macro environment. ... enterprise technology is going to remain a strong grower somewhere in the 5%, 6%, 7% range." — Arvind Krishna, CEO

Assessment: The tone upgrade from "cautious optimism" to "optimism" is the clearest sentiment shift on the call. It is encouraging, but CEO macro optimism is a soft data point; the hard data point (flat Consulting) still says discretionary demand is subdued.

Red Hat, OpenShift, and the virtualization opportunity

On Red Hat, management went broader than the virtualization question, describing high-single-digit growth in core RHEL boosted by AI workloads, OpenShift as the winning cross-cloud platform for both containers and virtualization as competitors exit the container market, and virtualization bookings that have now eclipsed $300M cumulatively.

Q: "How do you see virtualization starting to contribute to that growth, especially given the acquisition of VMware by Broadcom and the price increases?"
— Amit Daryanani, Evercore ISI

A: "If people are wanting a container platform that goes across public cloud and on-premise, I will tell you that we are the leading answer for that. ... there is a set of clients who would prefer a common answer across containerization and virtualization. And then by default, we tend to win those." — Arvind Krishna, CEO

Assessment: The Broadcom-VMware disruption is a real, multi-year share-gift to OpenShift virtualization, and it is one of the cleaner organic growth levers in the Software portfolio. This is a tailwind we would underwrite.

watsonx Orchestrate and the right to win in agentic AI

The final exchange probed IBM's differentiation in agent orchestration, a crowded space. The CEO's answer leaned on IBM's heterogeneity: unlike vendors pushing only their own agents, Orchestrate manages bespoke and third-party agents (roughly 70 built-in, plus ~70 third-party) across model providers, which he framed as the winning posture for clients who want a vendor-neutral control plane.

Q: "On the Orchestrate layer ... a lot of companies have started to talk about ... model orchestration or agentic orchestration. If you could just talk a little more about your right to win in that space."
— Matt Swanson, RBC Capital Markets

A: "If it is only about your own agent, I actually think that those are our partners, those are not people we compete with. ... there are going to be agents that come from different places, and people want their own bespoke agents. That is the client where we are going to win in Orchestrate." — Arvind Krishna, CEO

Assessment: The heterogeneity argument is IBM's most credible AI-differentiation claim, consistent with its decades-long middleware positioning. Whether it converts to material software revenue is unproven, but the strategic logic is sound and plays to IBM's actual strengths rather than chasing frontier-model economics.

What They're NOT Saying

1. An explicit organic Software growth rate: Management repeatedly cited reported and constant-currency Software growth but never volunteered a clean organic figure, leaving the analyst's "3% to 4%" estimate to stand unrebutted. In a quarter where organic composition was the whole debate, the omission was conspicuous.
2. A raised revenue guide: With margin, EBITDA, cash, and productivity all lifted, the conspicuous hold-out was the top line. Reaffirming rather than raising 5% cc after a first-half beat is a quiet signal about confidence in the second-half Software composition.
3. Consulting signings quality beyond the renewal explanation: The 18% signings decline was attributed entirely to prior-year renewal comps, but management did not quantify how much of the healthy backlog is durable versus low-margin, nor give a timeline for Consulting revenue to inflect positive.
4. The HashiCorp/DataStax organic-versus-inorganic split: Acquisitions contributed materially to Automation and Data growth, but IBM did not break out the inorganic contribution, which is exactly the number needed to judge whether the double-digit Software guide is organically supported.
5. A quantified 2026 framework: The CEO offered "equal or higher" 2026 Software growth qualitatively but the CFO explicitly declined to put numbers on it ("way too early"), so the 2026 acceleration remains a directional assertion.

Market Reaction

• Pre-print setup: IBM entered the print at $282.01, near all-time highs, up 28.3% year-to-date and 53.2% over the trailing twelve months, having outrun the S&P 500 (up ~8% YTD) by a wide margin. The 52-week closing range was $183.25 to $294.78. A stock priced for perfection sets a high bar for any single data point.
• Reaction session (July 24): Shares fell 7.6% to $260.51, a $21.50 decline, gapping down 7.4% at the open ($261.25) and trading as low as $252.75 intraday before closing near the lows. Volume of 22.6M shares was 6.1x the 30-day average, a decisive repricing rather than a drift.
• Peer/context: The move came against an essentially flat S&P 500 (+0.1% on the session), so this was IBM-specific, not a market event.

The reaction is a textbook "priced-for-acceleration" repricing. IBM beat both lines and raised cash and margin guidance, but the market has re-rated the stock over the past year on the premise that Software is inflecting to double digits, and the single most-scrutinized number, Software revenue, came in about 1.3% light against the Street with organic growth decelerating. When a name trades near all-time highs at roughly 24x forward operating earnings, the burden of proof sits with the company on its highest-multiple segment, and a small miss there outweighs a clean consolidated beat. The 6x volume says this was position-squaring by holders who had underwritten the acceleration, not a fundamental reassessment of the franchise.

Street Perspective

Debate: Is the Software acceleration real or an M&A mirage?

Bull view: The bull case holds that reported Software growth of 8% cc understates the trajectory because Transaction Processing is a temporary, cycle-driven drag that reverses as z17 capacity converts, and that Red Hat's mid-teens durability plus HashiCorp synergies carry the segment to double digits regardless of a soft quarter.

Bear view: The bear camp argues that stripping out HashiCorp and DataStax leaves organic Software at 3-4% and decelerating, that the double-digit guide is therefore an M&A-and-hope construction, and that a company buying its way to a growth rate does not deserve a growth multiple.

Our take: The bears have the better of the near-term read and the bulls the better of the two-year read. Organic Software genuinely decelerated, and the guide is back-half-loaded and M&A-assisted; that justifies caution today. But the z17-to-Transaction-Processing conversion and the Broadcom-VMware share gift to OpenShift are real organic levers that should show up in 2026. This is why we initiate at Hold rather than Underperform: the composition is not yet proven, but the levers to prove it exist.

Debate: Does the free-cash-flow strength justify the multiple?

Bull view: At >$13.5B of free cash flow and a ~5.6% free-cash-flow yield, IBM is one of the cheapest large-cap compounders on a cash basis, with a self-funded productivity lever ($4.5B target) driving margin expansion independent of the macro and a bulletproof 2.6% dividend.

Bear view: Free-cash-flow yield is flattered by low capital intensity and financing dynamics, and a 24x forward-earnings multiple on a 5% grower is expensive however you frame the cash; the re-rating has already happened, leaving limited multiple upside.

Our take: Both are right, which is the definition of a Hold. The cash generation and productivity flywheel are genuinely high quality and put a firm floor under the stock. But the multiple has already captured the good news, and further upside requires the growth rate to validate the re-rating rather than the cash to re-underwrite it. We would be more constructive on a pullback that restored a margin of safety on the growth premium.

Debate: Is Consulting a value trap inside a software story?

Bull view: Consulting has stabilized off the fourth-quarter trough, backlog is up 8%, and the GenAI book (now >$6B in consulting) positions IBM as the deployment partner of choice, turning AI disruption into a tailwind.

Bear view: The CEO himself said the AI wave cannibalizes labor-based services; Consulting is IBM's most macro-exposed, lowest-margin segment, and a flat-to-declining 30%-of-revenue drag caps the consolidated growth rate no matter how well Software does.

Our take: We side with the skeptics on Consulting as a growth asset but not as a disaster. It is a stabilizing, cash-generative, structurally challenged business that will likely tread water; the realistic bull outcome is "stops being a drag," not "becomes an engine." We model it flat and treat any signings inflection as upside.

Model Update Needed

Valuation impact: At the post-print $260.51, IBM trades at roughly 24x our ~$10.95 FY25 operating EPS and a ~5.6% free-cash-flow yield. A fair-value framework anchored on ~22-24x forward operating earnings and a stable dividend supports a range around $250-285, which brackets the current price. That symmetry is the arithmetic behind the Hold: the cash flow caps the downside near current levels, while the growth premium caps the upside until organic Software validates the re-rating.

Thesis Scorecard Post-Earnings

Overall: Thesis established at initiation. IBM is a genuinely improving business, cash-rich, margin-expanding, and executing a credible hybrid-cloud-and-AI pivot, but the equity has already re-rated to price much of that improvement, and the growth engine (organic Software) has not yet demonstrated the acceleration the multiple assumes.

Action: Initiate at Hold. Own the cash flow and the productivity flywheel; wait for organic Software to validate the double-digit guide, or for a pullback that restores a margin of safety, before paying up. We would turn constructive on evidence of organic Software reacceleration (particularly a Transaction Processing rebound) or a de-rating toward the low-$240s; we would turn cautious on a further organic deceleration or a Consulting relapse.